CRISPR and the bioethics of inherited privilege

This paper examines the implications of creating a technocratic elitism in society where advancements in such medical technologies as “designer babies” pose significant threats. The power to rewrite human heredity is no longer confined to speculative fiction. Germline treatments extend these abilities to future generations, posing significant ethical questions of social justice, input, and perfection, even as somatic gene modification promises medicinal hope for healing disorders inside humans. Germline editing transfers changes to offspring, whereas somatic editing works within a single body’s genome and seeks to treat conditions. Because medicinal use and augmentation frequently overlap in language but differ in moral authority, thus, this distinction is essential to bioethics. This paper offers a humanities centered critique of “designer babies,” emphasizing the ethical concerns, societal (maybe racial) implications, and justice-related challenges surrounding embryonic gene editing. It argues that unregulated germ-line interventions risk solidifying social inequalities by creating a new form of inherited privilege that undermines the principles of democratic fairness. The analysis concludes with policy recommendations grounded in solidarity and global equity.